跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUPEMTEK - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SUPEMTEK
Authorized
STANDARD
SUPEMTEK
Sanofi Pasteur Limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
55fb3358cc96ad75
Company
Sanofi Pasteur Limited
Type
Standard
Approval Details
Approval Id
55fb3358cc96ad75
Drug Approval Canada Name
SUPEMTEK
Product Name
SUPEMTEK
Status
Dormant
Status Date
2024-01-17
Original Market Date
2022-10-03
Din
02510936
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular
Schedule
Schedule D
Ahfs
80:12.00
Atc Original
J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Atc Name
j 07 bb 02
Aig Number
0462721001
Company Name
Sanofi Pasteur Limited
Company Address
1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4
Company Detail Path
/organization/sanofi-pasteur-limited
Company Information
Pharmaceutical Company Name
Sanofi Pasteur Limited
Country Name
Canada
Province Name
Ontario
City Name
north york,ontario,country_ca
Address
1755 Steeles Ave W
Active Ingredients
RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A (H1N1)
45 MCG / 0.5 ML
RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (VICTORIA)
45 MCG / 0.5 ML
RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A (H3N2)
45 MCG / 0.5 ML
RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (YAMAGATA)
45 MCG / 0.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
55fb3358cc96ad75
Type
Standard
Back to Health Canada Approvals